https://www.selleckchem.com/pr....oducts/b102-parp-hda
Predicting morbidity for patients with locally advanced cervix cancer after external beam radiotherapy (EBRT) based on dose-volume parameters remains an unresolved issue in definitive radiochemotherapy. The aim of this prospective study was to correlate patient characteristics and dose-volume parameters to various early morbidity endpoints for different EBRT techniques, including volumetric modulated arc therapy (VMAT) and adaptive radiotherapy (ART). The study population consisted of 48patients diagnosed with locally advanc
Мне нравится
Комментарий
Перепост
